What shapes HIV-1 Envelope gp41 antibody response?
This article, published in Cell Host & Microbe, looked at human immunodeficiency virus, type 1 (HIV-1) Envelope gp41 antibodies. (Gp41 is a protein on the surface of HIV that helps the virus invade the host's cells; it is of interest to
This article, published in Cell Host & Microbe, looked at human immunodeficiency virus, type 1 (HIV-1) Envelope gp41 antibodies. (Gp41 is a protein on the surface of HIV that helps the virus invade the host’s cells; it is of interest to those aiming to develop HIV vaccines.)
Researchers wanted to know what shaped gp41 antibody response to HIV-1. Their findings supported the hypothesis that the dominant HIV-1 gp41 antibody response after HIV-1 transmission is mediated by previously-activated memory B cells in the intestine. These cells are present even before HIV-1 infection and are cross-reactive with intestinal bacteria.
The preinfection B cell repertoire to environmental antigens shapes the postinfection B cell response to HIV-1. Commensal bacteria, as part of the preinfection ‘environment’, may play critical roles in shaping the response to HIV-1.
HIV-1 Envelope gp41 Antibodies Can Originate from Terminal Ileum B Cells that Share Cross-Reactivity with Commensal Bacteria
Trama, et al. (2014) HIV-1 Envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria. Cell Host & Microbe. http://dx.doi.org/10.1016/j.chom.2014.07.003
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014. Find her on: Google • Twitter
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.